Press Releases

Featured Press Releases

BIO Statement on Reintroduction of the PASTEUR Act

WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the reintroduction of the bipartisan Pioneering Antimicrobial Subscriptions to End Upsurging Resistance …

Learn more

BIO Statement on Passage of Bipartisan…

WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement.“The passage of the Mikaela Naylon Give Kids a Chance Act is a bipartisan victory for children and…

Learn more

BIO Appoints Joe Franklin, JD, PhD, as Chief…

Washington, D.C. (February 2, 2026) -- The Biotechnology Innovation Organization (BIO) today named Joe Franklin, JD, PhD, as its new chief legal and policy officer. Franklin brings deep expertise in the biomedical sector across law, policy, AI, and…

Learn more

BIO Releases First Report in a Series on the State of Innovation in Highly Prevalent Chronic Diseases

January 18, 2018

First-of-its-kind report highlights the need to stimulate development efforts for depression therapeutics. Washington, DC (January 18, 2018) – Today, the Biotechnology Innovation Organization (BIO) released a new report, The State of…

BIO Statement on House Energy & Commerce Committee 340B Drug Pricing Program Review

January 10, 2018

Washington, DC (January 10, 2018) – BIO President and CEO Jim Greenwood issued the following statement regarding the review of the 340B drug pricing program released by the House Energy & Commerce Committee today:

BIO Applauds Support for Innovation in Trump Administration Task Force Report

January 9, 2018

“Biotechnology Sector is a Driver of the ‘Fourth Industrial Revolution’”Washington, D.C. (January 9, 2018) – The Biotechnology Innovation Organization (BIO) is applauding a new report from the Interagency Task Force on Agriculture and Rural…

BIO Statement on Retirement of Senator Orrin Hatch

January 2, 2018

Washington, DC (January 2, 2018) – “BIO joins the nation – and the great state of Utah – in applauding Senator Hatch for his many years of service, and for proving time and time again to be a strong champion for biomedical innovation."

BIO Applauds House Passage of the Corporate Governance Reform and Transparency Act

December 21, 2017

Washington, DC (December 21, 2017) – Today, the Biotechnology Innovation Organization (BIO) applauds the House of Representatives for passing H.R. 4015, the Corporate Governance Reform and Transparency Act. This bipartisan bill, sponsored…

BIO Applauds USTR for Standing Up for Ag Innovation and Sound Science

December 14, 2017

U.S. Government and 16 like-minded WTO Members Call forImplementation of the Sanitary and Phytosanitary (SPS) AgreementWashington, D.C. (December 14, 2017) – The Biotechnology Innovation Organization (BIO) is applauding efforts by the United States…

Dynamic Speaker Lineup Announced for BIO CEO & Investor Conference

December 14, 2017

The Biotechnology Innovation Organization (BIO) today announces preliminary programing for the upcoming BIO CEO & Investor Conference to be held February 12-13, 2018 in New York. The program will include a diverse group of industry luminaries at…

2018 RFS Volumes Set Back Growth in Cellulosic Biofuels

November 30, 2017

BIO is disappointed that EPA did not raise the Renewable Fuel Standard's advanced and cellulosic biofuel volumes for 2018 in line with the industry’s ability to produce them.

BIO Applauds Sens. Tillis and Peters for Introducing the Fostering Innovation Act

November 15, 2017

Washington, DC (November 15, 2017) – Today, the Biotechnology Innovation Organization (BIO) applauds Sens. Thom Tillis (R-NC) and Gary Peters (D-MI) for introducing the Fostering Innovation Act. This vital legislation would build on the…

BIO Statement on Senate GOP Tax Reform Proposal

November 10, 2017

Washington, DC (November 10, 2017) – Biotechnology Innovation Organization (BIO) Senior Vice President of Communications Kenneth Lisaius released the following statement regarding the Senate GOP tax reform proposal.

Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.